Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bronchitol 40mg inhalation powder capsules with two devices
0307000R0BBAAAA
|
Bronchitol | Mannitol | Respiratory System | 6 |
|
Mannitol 100g/500ml (20%) infusion
0202050M0AAABAB
|
Mannitol (Osmotic Diuretic) | Mannitol | Cardiovascular System | No data available |
|
Mannitol 100g/500ml (20%) infusion Viaflex bags
0202050M0BCACAB
|
Baxter mannitol | Mannitol | Cardiovascular System | No data available |
|
Mannitol 40mg inhalation powder capsules with two devices
0307000R0AAAAAA
|
Mannitol | Mannitol | Respiratory System | No data available |
|
Mannitol 50g/250ml (20%) infusion bags
0202050M0AAAEAE
|
Mannitol (Osmotic Diuretic) | Mannitol | Cardiovascular System | No data available |
|
Mannitol 50g/250ml (20%) infusion Viaflex bags
0202050M0BCAIAE
|
Baxter mannitol | Mannitol | Cardiovascular System | No data available |
|
Mannitol 50g/500ml (10%) infusion
0202050M0AAAAAA
|
Mannitol (Osmotic Diuretic) | Mannitol | Cardiovascular System | No data available |
|
Mannitol 50g/500ml (10%) infusion Viaflex bags
0202050M0BCADAA
|
Baxter mannitol | Mannitol | Cardiovascular System | No data available |
|
Polyfusor mannitol 10% infusion 500ml bottles
0202050M0BDABAA
|
Polyfusor mannitol | Mannitol | Cardiovascular System | No data available |
|
Polyfusor mannitol 20% infusion 500ml bottles
0202050M0BDAAAB
|
Polyfusor mannitol | Mannitol | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.